Group I mGluR signaling in BSE-infected bovine-PrP transgenic mice

Neuroscience Letters

Volumn 410, Issue 2, 2006, Pages 115-120

  Rodríguez, Agustín ^a   Martín, Mairena ^c   Albasanz, José Luís ^c   Barrachina, Marta ^a   Espinosa, Juan Carlos ^d   Torres, Juan María ^d   Ferrer, Isidre ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^d Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria Consejo Superior de Investigaciones Científicas   (Spain)

Author keywords

Bovine spongiform encephalopathy; Metabotropic glutamate; Phospholipase C; Prion; Protein kinase C; Receptors

Indexed keywords

METABOTROPIC RECEPTOR 1; PHOSPHOLIPASE C; PHOSPHOLIPASE C BETA1; PRION PROTEIN; PRION PROTEIN PRPRES; PROTEIN KINASE C; PROTEIN KINASE C DELTA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; DENSITOMETRY; DISEASE COURSE; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; INOCULATION; MOUSE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN; CATTLE; DISEASE MODELS, ANIMAL; ENCEPHALOPATHY, BOVINE SPONGIFORM; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MICE; MICE, TRANSGENIC; PHOSPHOLIPASE C; PRIONS; PROTEIN KINASE C-DELTA; RECEPTORS, METABOTROPIC GLUTAMATE; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 33750685959     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.09.084     Document Type: Article

References (23)

1. Aguzzi A., Montrasio F., and Kaeser P.S. Prions: health scare and biological challenge. Nat. Rev. Mol. Cell. Biol. 2 (2001) 118-126
2. Budka H., Head M.W., Ironside J.W., Gambetti P., Parchi P., Zeidler M., and Tagliavini F. Sporadic Creutzfeldt-Jakob disease. In: Dickson D. (Ed). Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (2003), ISN Neuropath Press, Basel 287-297
3. Castilla J., Gutierrez-Adan A., Brun A., Pintado B., Salguero F.J., Parra B., Segundo F.D., Ramirez M.A., Rabano A., Cano M.J., and Torres J.M. Early detection of PrP(res) in BSE-infected bovine PrP transgenic mice. Arch. Virol. 148 (2003) 677-691
4. Collinge J. Prion diseases of human and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24 (2001) 519-550
5. Conn P.J. Physiological roles and therapeutic potential of metabotropic glutamate receptors. Ann. N. Y. Acad. Sci. 1003 (2003) 12-21
6. Conn P., and Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Ann. Rev. Pharmacol. Toxicol. 37 (1997) 205-237
7. Giese A., and Kretzschmar H.A. Prion-induced neuronal damage-the mechanisms of neuronal destruction in the subacute spongiform encephalopathies. Curr. Top. Microbiol. Immunol. 253 (2001) 203-217
8. Hamm H.E. The many faces of G protein signaling. J. Biol. Chem. 273 (1998) 669-672
9. Hammond C. The metabotropic glutamate receptors. Cellular and Molecular Neurobiology (2003), Academic Press, Amsterdam, Boston, Heidelberg, London, New York, Oxford, Paris, San Diego, San Francisco, Singapore, Sydney, Tokyo Chapter 14, pp. 314-326
10. Jaken S. Protein kinase C isozymes and substrates. Curr. Opin. Cell. Biol. 8 (1996) 168-173
11. Mellor H., and Parker P.J. The extended protein kinase C superfamily. Biochem. J. 332 (1998) 281-292
12. Michaelis E.K. Molecular biology of glutamate receptors in the central nervous system and their role in excitoxicity, oxidative stress and aging. Prog. Neurobiol. 54 (1998) 369-415
13. Newton A.C. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors and macromolecular interactions. Chem. Rev. 101 (2001) 2353-2364
14. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258 (1992) 607-614
15. Ogita K., Miyamoto S.I., Yamaguchi K., Koide H., Fujisawa N., Kikkawa U., Sahara S., Fukami Y., and Nishizuka Y. Isolation and characterization of δ-subspecies of protein kinase C from rat brain. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 1592-1596
16. Ozawa S., Kamiya H., and Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog. Neurobiol. 54 (1998) 518-618
17. Phillis J.W., and O'Regan M.H. A potential critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders. Brain Res. Rev. 44 (2004) 13-47
18. Pin J.P., and Acher F. The metabotropic glutamate receptors: structure, activation, mechanisms and pharmacology. Curr. Drug Target CNS Neural. Disord. 1 (2002) 297-317
19. Prusiner S.B. The prion diseases of humans and animals. In: Rosenber R.N., Prusiner S.B., DiMauro S., and Barchi R.L. (Eds). The Molecular and Genetic Basis of Neurological Diseases (1997), Butterworth-Heinemann, Boston 165-186
20. Rebecchi M.J., and Pentyala S.N. Structure, function, and control of phosphoinositide specific phospholipase C. Physiol. Rev. 80 (2000) 1291-1335
21. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70 (2001) 281-312
22. Rodríguez A., Freixes M., Dalfó E., Martín M., Puig B., and Ferrer I. Metabotropic glutamate receptor/phospholipase C pathway: a vulnerable target to Creutzfeldt-Jakob disease in the cerebral cortex. Neuroscience 131 (2005) 825-832
23. Scallet A.C., and Ye X. Excitotoxic mechanisms of neurodegeneration in transmissible spongiform encephalopathies. Ann. N. Y. Acad. Sci. 825 (1997) 194-205